How many insider declarations has Sims Karen filed?

Sims Karen has filed 3 public insider declarations with SEC (Form 4).

What is Sims Karen's role?

Sims Karen's reported role is not specified by the regulator across the filings.

Which companies does Sims Karen report trades for?

Sims Karen reports trades for Arbutus Biopharma Corp.

What is Sims Karen's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 62k€.

← Executives ★ Sign in to follow

SK

Sims Karen

OFFICER

·SEC (Form 4)

Arbutus Biopharma Corp

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€61,506

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the complete record of transactions filed by Sims Karen. Officer active across 1 company, notably Arbutus Biopharma Corp. In total, 3 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €62k. History available since 1 February 2024. The latest transaction was disclosed on 14 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Sims Karen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Arbutus Biopharma Corp (US)

Declarations3 total

◆

Sims Karen

Chief Medical OfficerExecutives14 Feb 2025Arbutus Biopharma Corp

0SEC ↗

49,300 shares0Common SharesSEC:0001447028-25-000049:0

▼

Sims Karen

Chief Medical OfficerExecutives4 Feb 2025Arbutus Biopharma Corp

$63,51937SEC ↗

19,348 shares@ US$3.283100.0% of flowCommon SharesSEC:0001447028-25-000039:0

◆

Sims Karen

Chief Medical OfficerExecutives1 Feb 2024Arbutus Biopharma Corp

0SEC ↗

101,000 shares0Common SharesSEC:0001447028-24-000028:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

SK

Sims Karen

OFFICER

·SEC (Form 4)

Arbutus Biopharma Corp

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€61,506

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the complete record of transactions filed by Sims Karen. Officer active across 1 company, notably Arbutus Biopharma Corp. In total, 3 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €62k. History available since 1 February 2024. The latest transaction was disclosed on 14 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.